<DOC>
	<DOCNO>NCT02547597</DOCNO>
	<brief_summary>There data regard anti-anginal effect beta-blockers without vasodilating property . Beta-blocker without vasodilating property generally know unfavorable effect glucose lipid metabolism . Therefore , investigator compare carvedilol atenolol anti-anginal metabolic effect patient stable angina pectoris .</brief_summary>
	<brief_title>Comparison Carvedilol Atenolol Anti-anginal Metabolic Effects Patients With Stable Angina Pectoris</brief_title>
	<detailed_description>Previous study demonstrate beta-blockers effective reduce ischemia also cardiovascular mortality follow myocardial infarction . And , recent guideline suggest potential use beta-blockers first-line agent chronic stable angina . However , beta-blockers diverse class different mechanism action physiological effect . Various pharmacologic property characterize beta-blockers include cardioselectivity , intrinsic sympathomimetic activity , concomitant vasodilating alpha-adrenoceptor blockade , might exhibit differential anti-anginal efficacy . In addition , traditional beta-blockers , particularly nonvasodilating beta-blockers , report negative metabolic effect , include hyperglycemia , insulin resistance , dyslipidemia . These unfavorable effect beta-blockers consider patient stable angina pectoris , pathophysiology coronary artery disease associate abnormality glucose lipid metabolism . Carvedilol , new vasodilating beta-blocker , show differ traditional beta-blockers term metabolic effect patient hypertension diabetes . However , data regard comparative anti-anginal metabolic effect beta-blockers without vasodilating property report , particularly patient angina pectoris . In study , simultaneously compare anti-anginal metabolic effect carvedilol atenolol patient stable angina pectoris .</detailed_description>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<mesh_term>Atenolol</mesh_term>
	<criteria>Stable angina pectoris positive exercise treadmill test accord American College Cardiology Foundation American Heart Association guideline Acute coronary syndrome Coronary revascularization within past 3 month Asthma chronic obstructive lung disease Bradycardia ( heart rate &lt; 55 beat/min ) History severe adverse reaction betablockers Symptomatic arrhythmia require antiarrhythmia therapy Heart failure Severe renal hepatic failure</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Beta-blockers</keyword>
	<keyword>Anti-anginal effect</keyword>
	<keyword>Lipid metabolism</keyword>
	<keyword>Glucose metabolism</keyword>
</DOC>